Periconceptie zorg en onderzoek
Conditions
Interventions
A vaginal self-swab is performed by the patient.
For women of European origin randomization in one of the following groups:
SDM group: Using Shared-Decision-Making according to the ReceptIVFity
mi
Sponsors
Erasmus MC, Universitair Medisch Centrum Rotterdam
Eligibility
Age
18 Years to 64 Years
Inclusion criteria
Inclusion criteria: 1. Naïve and non-naïve IVF or IVF/ICSI patients. 2. 18 years
Exclusion criteria
Exclusion criteria: 1. The use of hormonal contraceptives at the time of taking the test. 2. The use of antibiotic treatment at the time of taking the test. 3. Emergency IVF for cancer or other reasons. 4. Women having IVF for egg preservation reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - Successful pregnancy (dichotomous), i.e., a pregnancy with a positive heartbeat at 12 weeks of gestation, - The number of the successful IVF or IVF/ICSI cycle - The total number of IVF or IVF/ICSI treatment cycles per patient. | — |
Secondary
| Measure | Time frame |
|---|---|
| - Scores of the SDM-Q-9 (questionnaire for patient satisfaction), which consists of nine statements that can be rated on a six-point scale from 0= *completely disagree* to 5= *completely agree*. - The total costs of all received treatments within the study period. -The primary endpoints given above for the women of non-European origin included in the observational part of this study. - The primary endpoints given above for women with endometriosis grade III and IV. | — |
Countries
Netherlands
Outcome results
None listed